147 research outputs found

    Detection of PrPres in the spleen of hamsters used as an in vivo model for experimental TSE

    Get PDF
    In order to detect the presence of PrPres in the spleen of infected hamsters, we used a newly developed extraction method, before Western blot analysis, allowing the precipitation of PrPres. The NaPTA treatment applied before proteolysis causes a change in the PK cleavage site, resulting in the generation of larger PrPres fragments, acting on the N-terminal region of PrPres. By using this procedure, with some modifications, we succeeded in detecting the prion protein in the spleen and obtained the expected bands of prion protein, while in previous reports only very weak signals were obtained. Moreover, it was possible to confirm that the amount of detectable PrPres in the hamster spleen is very low, suggesting that the spleen plays a non-essential role for development of the disease in the hamster experimental model

    Mineralogical and geochemical characterisation of open-air tailing and waste-rock dumps from the Libiola Fe-Cu sulphide mine (Eastern Liguria, Italy)

    Get PDF
    Active acid mine drainage (AMD) processes at the Libiola Fe-Cu sulphides mine are mainly triggered by water–rock interaction occurring within open-air tailing and waste-rock dumps. These processes are mainly controlled by exposure to weathering agents, the grain size of the dumped materials, and by the quantity of sulphides, the sulphide types, and their mode of occurrence. Due to these factors, several paragenetic stages of evolution have been recognised at different depths at different sites and within the same site. The dump samples were investigated with mineralogical (reflected- and transmitted-light optical microscopy, XRPD, and SEM-EDS) and geochemical (ICP-AES, Leco) techniques. The AMD evaluation of the tailing and waste-rock samples was performed by calculating the Maximum Potential Acidity, the Acid Neutralising Capacity, (and the Net Acid Producing Potential. The results allowed us to demonstrate that the open-air tailings had already superseded their AMD apex and are now practically inert material composed mainly of stable goethite ± lepidocrocite ± hematite assemblages. On the contrary, the sulphide-rich waste rocks still have a strong potential to produce long term AMD, causing the acidification of circulating waters and the release of several hazardous elements

    Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation

    Get PDF
    Background: The clinical characteristics of human metapneumovirus (hMPV)-associated lower respiratory tract infection (LRTI) after allogeneic hematopoietic stem cell transplantation (HSCT) is not well described. We describe the clinical course in eight HSCT recipients suffering from hMPV infection. Methods: We prospectively included all patients with hMPV-associated LRTI after allogeneic HSCT during a period of 1year. hMPV was diagnosed by multiplex polymerase chain reaction (PCR) from bronchoalveolar lavage (BAL). Results: Eight patients with hMPV-associated LRTI were identified from 93 BAL samples. Three of the eight patients had co-infections with other pathogens. The median age of the patients was 45years [interquartile range (IQR) 36.8-53.5], the median time posttransplant was 473days (IQR 251-1,165), 5/8 patients had chronic graft-versus-host disease (cGvHD), and 6/8 patients received immunosuppression. Chest computed tomography (CT) scanning showed a ground-glass pattern in 7/8 patients. Seven of eight patients required hospitalization due to severe symptoms and hypoxemia. All were treated with intravenous immunoglobulin (IVIG), which was combined with oral ribavirin in six patients. The mortality rate was 12.5% (1/8). Conclusions: hMPV-associated LRTI in allogeneic HSCT recipients are not uncommon and present with unspecific respiratory symptoms, ground-glass pattern in CT scanning, and co-infectio

    The future of Cybersecurity in Italy: Strategic focus area

    Get PDF
    This volume has been created as a continuation of the previous one, with the aim of outlining a set of focus areas and actions that the Italian Nation research community considers essential. The book touches many aspects of cyber security, ranging from the definition of the infrastructure and controls needed to organize cyberdefence to the actions and technologies to be developed to be better protected, from the identification of the main technologies to be defended to the proposal of a set of horizontal actions for training, awareness raising, and risk management

    Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide

    Get PDF
    In a two-stage phase II study, 24 patients with first diagnosis of glioblastoma (GBM) were treated with dendritic cell (DC) immunotherapy associated to standard radiochemotherapy with temozolomide (TMZ) followed by adjuvant TMZ. Three intradermal injections of mature DC loaded with autologous GBM lysate were administered before adjuvant TMZ, while 4 injections were performed during adjuvant TMZ. According to a two-stage Simon design, to proceed to the second stage progression-free survival (PFS) 12 months after surgery was expected in at least 8 cases enrolled in the first stage. Evidence of immune response and interaction with chemotherapy were investigated. After a median follow up of 17.4 months, 9 patients reached PFS12. In these patients (responders, 37.5%), DC vaccination induced a significant, persistent activation of NK cells, whose increased response was significantly associated with prolonged survival. CD8+ T cells underwent rapid expansion and priming but, after the first administration of adjuvant TMZ, failed to generate a memory status. Resistance to TMZ was associated with robust expression of the multidrug resistance protein ABCC3 in NK but not CD8+ T cells. The negative effect of TMZ on the formation of T cell-associated antitumor memory deserves consideration in future clinical trials including immunotherapy
    • …
    corecore